Latest filing: Sandu Pharmaceuticals Ltd - 524703 - Announcement Under Regulation 30-Reconstitution Of Committees Of Board-Audit/Nomination/Stakeholders
ObservedCompany dossier
Sandu Pharmaceuticals
BSE:SANDUPHQ · ISIN INE751D01014
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Sandu Pharmaceuticals
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest ownership: promoter group 37.79% and public 62.21% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Sandu Pharmaceuticals Ltd - 524703 - Announcement Under Regulation 30-Reconstitution Of Committees Of Board-Audit/Nomination/Stakeholders
BSE · exchange filing
Observed
Source filing Sandu Pharmaceuticals Ltd - 524703 - Board Meeting Outcome for Outcome Of The Board Meeting Dated 11.07.2026
BSE · exchange filing
Observed
Source filing Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Change in Directorate
BSE · exchange filing
Observed
Source filing Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · exchange filing
Reported financials
Full financials →Awaiting structured filing
No reconciled records in this module yet
Structured financial facts have not been reconciled.
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 37.79%
- Public
- 62.21%
- Employee trust
- N/A
Observed BSE shareholding XBRL